Characterization of isolated tau-reactive antibodies from the IVIG product, plasma of patients with Alzheimer's disease and cognitively normal individuals

被引：10
作者：
Krestova, Michala [1 ,2 ]
Hromadkova, Lenka [1 ,3 ,4 ]
Bilkova, Zuzana [4 ]
Bartos, Ales [1 ,2 ]
Ricny, Jan [1 ]
机构：
[1] Natl Inst Mental Hlth, Klecany, Czech Republic
[2] Charles Univ Prague, Fac Med 3, Prague, Czech Republic
[3] Charles Univ Prague, Fac Sci, Prague, Czech Republic
[4] Univ Pardubice, Dept Biol & Biochem Sci, Pardubice, Czech Republic
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2017年 / 313卷
关键词：
Alzheimer's disease; Brain homogenates; Plasma antibodies; Reactivity profile; Tau protein; INTRAVENOUS IMMUNOGLOBULIN PRODUCTS; NATURALLY-OCCURRING AUTOANTIBODIES; NEUROFIBRILLARY TANGLES; NEURONAL-ACTIVITY; PATHOLOGICAL TAU; ENDOGENOUS TAU; AMYLOID-BETA; A-BETA; IMMUNOTHERAPY; PROTEIN;
D O I：
10.1016/j.jneuroim.2017.09.011
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The presence of natural tau-reactive antibodies was reported in human blood. In this study, we isolated and characterized natural tau-reactive antibodies occurring in IVIG product Flebogamma, plasma of patients with Alzheimer's disease (AD) and older cognitively normal persons (controls). Using blotting immunoassays and ELISA, we showed reactivity of antibodies obtained from IVIG and controls against a recombinant fragment of tau (155-421 aa) and aggregates present in brains of AD patients. In contrast, antibodies isolated from plasma of AD patients reacted mainly with the recombinant full-length tau form and tau monomeric forms in brain tissue.
引用
收藏
页码：16 / 24
页数：9
相关论文
共 50 条
  • [21] Association between polygenic risk score of Alzheimer's disease and plasma phosphorylated tau in individuals from the Alzheimer's Disease Neuroimaging Initiative
    Zettergren, Anna
    Lord, Jodie
    Ashton, Nicholas J.
    Benedet, Andrea L.
    Karikari, Thomas K.
    Rodriguez, Juan Lantero
    Snellman, Anniina
    Suarez-Calvet, Marc
    Proitsi, Petroula
    Zetterberg, Henrik
    Blennow, Kaj
    ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
  • [22] Financial Capacity and Regional Cerebral Tau in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Dementia
    Gonzalez, Christopher
    Tommasi, Nicole S.
    Briggs, Danielle
    Properzi, Michael J.
    Amariglio, Rebecca E.
    Marshall, Gad A.
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 79 (03) : 1133 - 1142
  • [23] Alzheimer's disease biomarkers as predictors of trajectories of depression and apathy in cognitively normal individuals, mild cognitive impairment,and Alzheimer's disease dementia
    Banning, Leonie C. P.
    Ramakers, Inez H. G. B.
    Rosenberg, Paul B.
    Lyketsos, Constantine G.
    Leoutsakos, Jeannie-Marie S.
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2021, 36 (01) : 224 - 234
  • [24] Development and characterization of novel anti-acetylated tau monoclonal antibodies to probe pathogenic tau species in Alzheimer's disease
    Bryan III, Miles R.
    Tian, Xu
    Tseng, Jui-Heng
    Evangelista, Baggio A.
    Ragusa, Joey V.
    Bryan, Audra F.
    Trotman, Winifred
    Irwin, David
    Cohen, Todd J.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2024, 12 (01):
  • [25] Cognitive reserve and rate of change in Alzheimer's and cerebrovascular disease biomarkers among cognitively normal individuals
    Pettigrew, Corinne
    Soldan, Anja
    Zhu, Yuxin
    Cai, Qing
    Wang, Mei-Cheng
    Moghekar, Abhay
    Miller, Michael, I
    Singh, Baljeet
    Martinez, Oliver
    Fletcher, Evan
    DeCarli, Charles
    Albert, Marilyn
    NEUROBIOLOGY OF AGING, 2020, 88 : 33 - 41
  • [26] Precision estimates of relative and absolute cerebral blood flow in Alzheimer's disease and cognitively normal individuals
    Heeman, Fiona
    Visser, Denise
    Yaqub, Maqsood
    Verfaillie, Sander
    Timmers, Tessa
    Pijnenburg, Yolande A. L.
    van der Flier, Wiesje M.
    van Berckel, Bart N. M.
    Boellaard, Ronald
    Lammertsma, Adriaan A.
    Golla, Sandeep S., V
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2023, 43 (03) : 369 - 378
  • [27] Cerebrospinal fluid from Alzheimer's disease patients promotes tau aggregation in transgenic mice
    Skachokova, Zhiva
    Martinisi, Alfonso
    Flach, Martin
    Sprenger, Frederik
    Naegelin, Yvonne
    Steiner-Monard, Viviane
    Sollberger, Marc
    Monsch, Andreas U.
    Goedert, Michel
    Tolnay, Markus
    Winkler, David T.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2019, 7 : 72
  • [28] Regional analysis of differently phosphorylated tau proteins in brains from patients with Alzheimer's disease
    Nakano, H
    Kobayashi, K
    Sugimori, K
    Shimazaki, M
    Miyazu, K
    Hayashi, M
    Furuta, H
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 17 (03) : 122 - 131
  • [29] Plasma β-amyloid, tau, neurodegeneration biomarkers and inflammatory factors of probable Alzheimer's disease dementia in Chinese individuals
    Sun, Qingling
    Ni, Jingnian
    Wei, Mingqing
    Long, Siwei
    Li, Ting
    Fan, Dongsheng
    Lu, Tao
    Shi, Jing
    Tian, Jinzhou
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [30] Brain 11β-Hydroxysteroid Dehydrogenase Type 1 Occupancy by XanamemT Assessed by PET in Alzheimer's Disease and Cognitively Normal Individuals
    Villemagne, Victor L.
    Dore, Vincent
    Chong, Lee
    Kassiou, Michael
    Mulligan, Rachel
    Feizpour, Azadeh
    Taylor, Jack
    Roesner, Miriam
    Miller, Tamara
    Rowe, Christopher C.
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 97 (03) : 1463 - 1475
12345